ZEN Graphene Solutions Ltd (ZTEK)

Official site

HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

$0.49

+0.00 (+0.00%)

Market Cap: $62.30M

Last updated: Sep 02, 2026 at 5:00 PM ET

Earnings

Performance (10Y)

Beat Rate

40%(2/5)

Avg Surprise

-18.40%

Streak

1 Q

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Jun 30, 2026Jun 26 Reported Jul 1, 2026Reported Jul 1	$-0.01	N/A	-	N/A	Beat	-	-	+0.0%
Mar 31, 2026Mar 26 Reported Jun 25, 2026Reported Jun 25	$-0.03	N/A	-	N/A	Beat	-	-	-50.0%
Dec 31, 2025Dec 25 Reported Feb 17, 2026Reported Feb 17	$-0.02	N/A	-	N/A	Beat	-	-	+16.5%
Sep 30, 2025Sep 25 Reported Nov 13, 2025Reported Nov 13	$-0.02	N/A	-	N/A	Beat	-	-	+23.5%
Jun 30, 2025Jun 25 Reported Aug 14, 2025Reported Aug 14	$-0.01	N/A	-	N/A	Beat	-	-	+45.9%
Mar 31, 2025Mar 25 Reported Jun 26, 2025Reported Jun 26	$-0.02	N/A	-	N/A	Beat	-	-	-10.5%
Dec 31, 2024Dec 24 Reported Feb 12, 2025Reported Feb 12	$-0.02	N/A	-	N/A	Beat	-	-	-2.6%
Sep 30, 2024Sep 24 Reported Nov 13, 2024Reported Nov 13	$-0.02	N/A	-	N/A	Beat	-	-	+13.9%
Jun 30, 2024Jun 24 Reported Jun 30, 2024Reported Jun 30	$-0.02	N/A	-	N/A	Beat	-	-	+21.6%
Mar 31, 2024Mar 24 Reported Jun 26, 2024Reported Jun 26	$-0.02	N/A	-	N/A	Beat	0	No revisions (30d)	+10.8%
Dec 31, 2023Dec 23 Reported Feb 12, 2024Reported Feb 12	$-0.02	N/A	-	N/A	Beat	-	-	+35.0%
Sep 30, 2023Sep 23 Reported Nov 13, 2023Reported Nov 13	$-0.03	N/A	-	N/A	Beat	-	-	+37.0%
Jun 30, 2023Jun 23 Reported Aug 11, 2023Reported Aug 11	$-0.02	$0.00	$0.00 - $0.00	N/A	Beat	0	No revisions (30d)	+52.8%
Mar 31, 2023Mar 23 Reported Jun 29, 2023Reported Jun 29	$-0.02	N/A	-	N/A	Beat	0	0 1 30d	+49.4%
Dec 31, 2022Dec 22 Reported Feb 10, 2023Reported Feb 10	$-0.03	$-0.03	-	+0.00%	Beat	-	-	-81.8%
Sep 30, 2022Sep 22 Reported Nov 14, 2022Reported Nov 14	$-0.04	$-0.03	-	-33.33%	Miss	-	-	-54.4%
Jun 30, 2022Jun 22 Reported Aug 5, 2022Reported Aug 5	$-0.05	$-0.04	-	-25.00%	Miss	-	-	-190.7%
Mar 31, 2022Mar 22 Reported Jun 29, 2022Reported Jun 29	$-0.04	$-0.03	-	-33.67%	Miss	-	-	-254.9%
Dec 31, 2021Dec 21 Reported Feb 28, 2022Reported Feb 28	$-0.02	N/A	-	N/A	Beat	-	-	+0.6%
Sep 30, 2021Sep 21 Reported Nov 29, 2021Reported Nov 29	$-0.03	N/A	-	N/A	Beat	-	-	-564.1%
Jun 30, 2021Jun 21 Reported Aug 27, 2021Reported Aug 27	$-0.02	N/A	-	N/A	Beat	-	-	-437.5%
Mar 31, 2021Mar 21 Reported Mar 31, 2021Reported Mar 31	$-0.01	N/A	-	N/A	Beat	-	-	-91.5%
Dec 31, 2020Dec 20 Reported Feb 26, 2021Reported Feb 26	$-0.02	N/A	-	N/A	Beat	-	-	-1006.7%
Sep 30, 2020Sep 20 Reported Nov 24, 2020Reported Nov 24	$-0.00	N/A	-	N/A	Beat	-	-	-5.4%
Jun 30, 2020Jun 20 Reported Aug 27, 2020Reported Aug 27	$-0.00	N/A	-	N/A	Beat	-	-	+15.8%
Mar 31, 2020Mar 20 Reported Mar 31, 2020Reported Mar 31	$-0.01	N/A	-	N/A	Beat	-	-	+3.3%
Dec 31, 2019Dec 19 Reported Feb 28, 2020Reported Feb 28	$-0.00	N/A	-	N/A	Beat	-	-	+76.6%
Sep 30, 2019Sep 19 Reported Nov 15, 2019Reported Nov 15	$-0.00	N/A	-	N/A	Beat	-	-	+68.9%
Jun 30, 2019Jun 19 Reported Aug 26, 2019Reported Aug 26	$-0.00	N/A	-	N/A	Beat	-	-	-22.6%
Mar 31, 2019Mar 19 Reported Mar 31, 2019Reported Mar 31	$-0.01	N/A	-	N/A	Beat	-	-	-17.3%
Dec 31, 2018Dec 18 Reported Feb 28, 2019Reported Feb 28	$-0.01	N/A	-	N/A	Beat	-	-	-64.1%
Sep 30, 2018Sep 18 Reported Nov 28, 2018Reported Nov 28	$-0.01	N/A	-	N/A	Beat	-	-	-221.6%
Jun 30, 2018Jun 18 Reported Aug 27, 2018Reported Aug 27	$-0.00	N/A	-	N/A	Beat	-	-	+51.6%
Mar 31, 2018Mar 18 Reported Mar 31, 2018Reported Mar 31	$-0.01	N/A	-	N/A	Beat	-	-	+33.3%
Dec 31, 2017Dec 17 Reported Feb 28, 2018Reported Feb 28	$-0.00	N/A	-	N/A	Beat	-	-	+61.0%
Sep 30, 2017Sep 17 Reported Nov 29, 2017Reported Nov 29	$-0.00	N/A	-	N/A	Beat	-	-	-
Jun 30, 2017Jun 17 Reported Aug 25, 2017Reported Aug 25	$-0.01	N/A	-	N/A	Beat	-	-	-
Mar 31, 2017Mar 17 Reported Mar 31, 2017Reported Mar 31	$-0.01	N/A	-	N/A	Beat	-	-	-
Dec 31, 2016Dec 16 Reported Feb 27, 2017Reported Feb 27	$-0.01	$-0.01	-	+0.00%	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	N/A	EV/EBITDA	N/A
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	0.00%	Operating Margin	-10104.00%
ROE	-53.20%	ROIC	N/A
Financial Health
Debt/Equity	N/A	Interest Coverage	N/A
Current Ratio	N/A	Quick Ratio	N/A
Trading Statistics
Beta	0.29	Avg Volume	N/A
52-Week High	$1.10	52-Week Low	$0.37

Technical Indicators Dashboard

Moving Averages

SMA 10$0.56

SMA 20$0.59

SMA 50$0.55

SMA 200$0.62

EMA 10$0.54

EMA 20$0.57

EMA 50$0.56

EMA 200$0.64

MACD

Line: -0.02Signal: 0.00Hist: -0.02

ADX

ADX: 24.9+DI: 14.3-DI: 26.1

Aroon & PSAR

Aroon Up32.0

Aroon Down92.0

PSAR$0.56

Bollinger Bands

Upper Band$0.70

Lower Band$0.49

%B Position3641%(Upper)

Band Width0.03

RSI (14-Day)

Neutral

31.5

Momentum Oscillators

Stoch %K31.5

Stoch %D22.6

Williams %R-71.5

ROC (10d)-15.4%

Momentum-0.09

CCI (20d)-161.5

MFI (14d)33.3

Volatility Measures

ATR (14d)$0.06(11.3%)

StdDev (20d)0.05

Hist Vol42.8%(High)

Volume Flow

VWAP$0.49

OBV6.9M

AD Line-5.7M

CMF (20d)-0.072

Volume Metrics

Avg Vol (20d)215.4K

Vol RatioN/A

VWMA (20d)$0.55

Pivot Points

R3$0.65

R2$0.61

R1$0.55

Pivot Point$0.50

S1$0.44

S2$0.39

S3$0.34

Advanced Oscillators

TSI-12.93

Ultimate Osc45.2

KST21.65

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$0	$36,861	$65,225	$6,204	$57,797	$813,596	$37,718	$15,692	$5,489	$5,757	$12,418	$11,641
Cost of Revenue	$1.22M	$2.98M	$1.34M	$6,972	$30,601	$267,504	$157,709	$217,732	$15,188	$130,884	$62,514	$142,728
Gross Profit	$-1,222,846	N/A	$-1,276,585	$-768	$27,196	$546,092	$-119,991	$-202,040	$-9,699	$-125,127	$-50,096	$-131,087

Operating Expenses	$966,593	$915,087	$1.49M	$2.08M	$1.83M	$2.65M	$2.48M	$2.13M	$2.56M	$2.35M	$2.81M	$3.33M
R&D	$242,134	$501,359	$744,015	$267,909	$140,794	$203,304	$165,605	$128,165	$31,421	$367,477	$409,977	$564,364
SG&A	$1.39M	$1.38M	$1.70M	$550,591	$1.33M	$2.11M	$1.92M	$1.64M	$2.24M	$1.68M	$2.11M	$2.31M
Operating Income	$-2,189,439	$-3,854,343	$-2,768,749	$-2,080,752	$-1,802,648	$-2,099,731	$-2,601,222	$-2,333,293	$-2,566,386	$-2,471,650	$-2,863,327	$-3,461,116

Interest Income	$29,717	$7,073	$6,820	$14,501	$11,914	$3,557	$24,803	$32,640	$40,613	$59,675	$96,793	$105,613
Interest Expense	$91,826	$82,544	$77,729	$48,183	$61,144	$181,419	$22,709	$223,652	$26,381	$20,965	$21,042	$21,876
Income Before Tax	$0	$-3,535,379	$-2,486,123	$-2,391,190	$-1,362,348	$-1,839,671	$-2,601,769	$-3,045,029	$-2,553,189	$-2,457,639	$-2,784,844	$-3,405,251
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$-3	$16,604	$-99,784	$57,519

Net Income	N/A	$-3,535,379	$-2,486,123	$-2,391,190	$-1,362,348	$-1,839,671	$-2,601,769	$-3,045,029	$-2,553,189	$-2,457,639	$-2,685,060	$-3,405,251

EBITDA	$-2,064,764	$-3,727,159	$-2,638,732	$-2,186,692	$-1,166,869	$-1,881,536	$-2,425,256	$-2,667,276	$-2,373,945	$-2,270,359	$-2,595,854	$-3,309,872
EBIT	$-2,189,438	$-3,854,342	$-2,768,749	$-2,283,686	$-1,301,204	$-2,021,090	$-2,579,060	$-2,821,377	$-2,526,808	$-2,430,961	$-2,757,907	$-3,461,116

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about ZTEK

News

ZENTEK LTD COM (ZEN.NE) latest stock news and headlines

This article provides the latest stock news and headlines for ZENTEK LTD COM (ZEN.NE), showing its current stock price and performance. A significant news item highlights Zentek's filing of a technical report confirming...

Yahoo Finance UK•Oct 15, 2026 8:13 PM ET10/15/26•Bullish

Zentek (TSXV:ZEN): Can Albany Graphite Meet Nuclear Purity Standards?

Zentek Ltd. (TSXV:ZEN) will present its Albany graphite purification results at the International Nuclear Graphite Specialists Meeting in Japan, seeking to determine if its ultra-high purity...

Kalkine Media•Oct 12, 2026 2:10 PM ET10/12/26•Neutral

Three graphite samples underpin Zentek (ZTEKF) purity results, but nuclear qualification remains unachieved.

Zentek Ltd. announced that its CEO will present Albany Graphite Project results at INGSM-26, showcasing bench-scale purification reaching 99.99985 wt.% carbon. While the company highlights this high purity and models its...

Stock Titan•Oct 7, 2026 9:30 AM ET10/7/26•Neutral

Zentek Reshapes Leadership to Drive ZenGUARD Commercialization and Capital Markets Reach

Zentek has announced a leadership team expansion aimed at accelerating the commercialization of its ZenGUARD technology and strengthening its presence in capital markets. The company appointed Angela Lomets as VP...

The Globe and Mail•Oct 7, 2026 1:10 AM ET10/7/26•Somewhat-Bullish

A new executive will lead sales of Zentek's air filters and protective gear starting Oct. 14.

Zentek (ZTEKF) has announced two new executive appointments to bolster ZenGUARD commercialization and investor relations, alongside the departure of a senior executive. Angela Lomets will join as VP...

Stock Titan•Oct 5, 2026 5:59 PM ET10/5/26•Neutral

ZTEK Profitability: Margins, ROIC and FCF

Operating margin: -10104.0%
Net margin: 0.0%
ROE: -53.2%

ZTEK Competitors

Company	Ticker
MDxHealth SA	MDXH
Tenax Therapeutics Inc	TENX
ImmunoPrecise Antibodies Ltd.	HYFT
Daxor Corporation	DXR
OS Therapies Incorporated	OSTX
Gain Therapeutics Inc	GANX
Rein Therapeutics Inc	RNTX
Connect Biopharma Holdings Ltd	CNTB

Sector: Healthcare

ZTEK Bull Case vs Bear Case

Bear case

ZTEK beat EPS estimates in 0.0% of its last 8 reported quarters.
ZTEK's quarterly revenue changed -95.5% year over year.

ZTEK Earnings: Beat Rate and Next Report

Beat rate: 0 of 8 quarters (0.0%)
Average surprise: -13.1%

Frequently Asked Questions About ZTEK

Does ZTEK pay dividends?

ZEN Graphene Solutions Ltd (ZTEK) does not currently pay a regular dividend.

What is ZTEK's market cap?

ZEN Graphene Solutions Ltd (ZTEK) has a market capitalization of $62.30M with a current stock price of $0.49.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In